Overview

Study to Compare the Effect of Ropinirole Prolonged Release Once-daily Versus Twice-daily

Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
1. In order to compare the benefit, side effects, and patient preference of Ropinirole prolonged release when used in once-daily or twice-daily dosing 2. In order to estimate the conversion rate of dopamine agonists into Ropinirole prolonged release
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Ropinirole